CAPSOVISION INC

CapsoVision CEO’s option exercise signals confidence in a strategic shift to high‑margin SaaS services, offering investors insight into upcoming margin expansion and recurring revenue growth.

CapsoVision insider buying signals confidence in its AI‑powered CapsoScope™ endoscopy platform—showing strong clinical benefits, low risk and potential upside for investors and clinicians alike.

CapsoVision’s insider shift from preferred to common shares signals bullish confidence: see how the Harari family’s buying spree reflects future earnings, cash‑flow, and tech‑driven growth.